Saliva microRNA Biomarkers of Cumulative Concussion
- PMID: 33092191
- PMCID: PMC7589940
- DOI: 10.3390/ijms21207758
Saliva microRNA Biomarkers of Cumulative Concussion
Abstract
Recurrent concussions increase risk for persistent post-concussion symptoms, and may lead to chronic neurocognitive deficits. Little is known about the molecular pathways that contribute to persistent concussion symptoms. We hypothesized that salivary measurement of microribonucleic acids (miRNAs), a class of epitranscriptional molecules implicated in concussion pathophysiology, would provide insights about the molecular cascade resulting from recurrent concussions. This hypothesis was tested in a case-control study involving 13 former professional football athletes with a history of recurrent concussion, and 18 age/sex-matched peers. Molecules of interest were further validated in a cross-sectional study of 310 younger individuals with a history of no concussion (n = 230), a single concussion (n = 56), or recurrent concussions (n = 24). There was no difference in neurocognitive performance between the former professional athletes and their peers, or among younger individuals with varying concussion exposures. However, younger individuals without prior concussion outperformed peers with prior concussion on three balance assessments. Twenty salivary miRNAs differed (adj. p < 0.05) between former professional athletes and their peers. Two of these (miR-28-3p and miR-339-3p) demonstrated relationships (p < 0.05) with the number of prior concussions reported by younger individuals. miR-28-3p and miR-339-5p may play a role in the pathophysiologic mechanism involved in cumulative concussion effects.
Keywords: biomarker; microRNA; mild traumatic brain injury; saliva; sports-related concussion.
Conflict of interest statement
S.D.H. is a paid consultant for Quadrant Biosciences Inc., Syracuse, NY, USA. S.D.H. is a scientific advisory board member for Quadrant Biosciences and is named as a co-inventor on intellectual property related to saliva RNA biomarkers in concussion that are patented by The Penn State College of Medicine and licensed to Quadrant Biosciences. S.D.V., G.F., and A.R. are paid employees of Quadrant Biosciences. C.N. is a member of the scientific advisory board and has equity interest in Quadrant Bioscience Inc.
Figures
References
-
- McCrory P., Meeuwisse W., Dvorak J., Aubry M., Bailes J., Broglio S., Cantu R.C., Cassidy D., Echemendia R.J., Castellani R.J. Consensus statement on concussion in sport—The 5th international conference on concussion in sport held in Berlin, October 2016. Br. J. Sports Med. 2017;51:838–847. - PubMed
-
- Pellman E.J., Powell J.W., Viano D.C., Casson I.R., Tucker A.M., Feuer H., Lovell M., Waeckerle J.F., Robertson D.W. Concussion in professional football: Epidemiological features of game injuries and review of the literature—Part 3. Neurosurgery. 2004;54:81–96. doi: 10.1227/01.NEU.0000097267.54786.54. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
